Table 4.
Characteristic | Odds ratio (CI) | P value |
---|---|---|
Ustekinumab doses | 0.4 (0.2–1.2) | 0.122 |
Failure of single or dual SIT agents | 0.05 (0.01–2.69) | 0.143 |
Total doses of SIT | 0.9 (0.6–1.3) | 0.576 |
Male sex | 0.22 (0.01–3.42) | 0.277 |
SIT, selective immunosuppressive therapy.